Yatharth Hospital & Trauma Care Services Ltd logo

Yatharth Hospital & Trauma Care Services Ltd

YATHARTH NSE

Key Fundamentals

MicrocapHospitalsHealthcare Services
Market Cap
₹8,261 Cr
Volatility
Moderate
P/E Ratio
45.43
EBITDA
₹292 Cr
Return on Equity
7.97%
Debt to Equity
0.15
Book Value
₹184.79
EPS
₹14.66
52W High
₹919.5
52W Low
₹538.25

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Yatharth Hospital & Trauma Care Services Ltd insights

42 extracted metrics + investor summaries across FY17–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 57.4% CAGR over last 5 years
  • Company's working capital requirements have reduced from 102 days to 80.1 days

Weaknesses

1
  • Company has a low return on equity of 12.1% over last 3 years.

Growth Rate

Revenue Growth
34.62% ↗
Net Income Growth
31.00% ↗
Cash Flow Change
4957.14% ↗
ROE
-39.11% ↘
ROCE
-37.63% ↘
EBITDA Margin (Avg.)
-10.16% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 42d ago
AI opinion · based on fundamentals
Risk high

Yatharth Hospital & Trauma Care Services is a mid-cap healthcare company with a market cap of Rs 8,296 Cr trading at a PE of 49x. The company has delivered strong revenue growth of 41% CAGR over 5 years and profit growth of 57% CAGR over the same period, though its return on equity has moderated to 10% in the last year from a 5-year average of 14%.

Bull Case 8
  • Exceptional 5-year compounded profit growth of 57% CAGR demonstrates strong operating leverage and scaling ability
  • Compounded sales growth of 41% CAGR over 5 years and 36% over 3 years indicates sustained revenue momentum in a growing healthcare market
  • TTM revenue growth remains robust at 40%, showing no meaningful deceleration from the 3-year trend of 36%
  • Working capital days have improved from 102 days to 80.1 days, reflecting better operational efficiency and cash conversion
  • Stock has delivered 50% returns over the past 1 year, indicating strong market confidence in the growth trajectory
  • TTM profit growth of 36% remains healthy and broadly in line with the 3-year CAGR of 39%
  • Company is expected to deliver a good quarter ahead, suggesting near-term earnings visibility remains intact
  • Price-to-book ratio of 4.68x is not extreme for a high-growth healthcare platform, suggesting the market is pricing in continued compounding
Bear Case 8
  • PE ratio of 49x is elevated and leaves little margin of safety if growth decelerates from current 36-40% levels
  • Return on equity has declined from a 5-year average of 14% to just 10% in the last year, signaling potential dilution of capital efficiency as the company expands
  • Zero dividend yield despite repeated profitability means shareholders rely entirely on capital appreciation for returns
  • 3-year ROE of only 12% is below the 15%+ threshold typically expected for a company commanding a 49x PE multiple
  • Debt-to-equity ratio is not disclosed, creating uncertainty about the leverage profile funding the aggressive expansion
  • Profit growth has decelerated from 57% CAGR over 5 years to 39% over 3 years and 36% TTM, suggesting the rate of earnings expansion may be plateauing
  • Limited listed history with no available 3-year, 5-year, or 10-year stock CAGR data makes it difficult to assess long-term shareholder value creation
  • At Rs 8,296 Cr market cap with a 49x PE, any quarterly miss or margin compression could trigger a sharp de-rating given the premium valuation

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 42d ago
Positives 1
  • Rs 100 Cr Gurugram acquisition Jun 12

    Yatharth Hospital completed acquisition of Gurugram assets worth Rs 100 Cr through subsidiary AKS Medical, expanding its geographic footprint in the NCR region.

Neutral 1
  • No promoter share encumbrance Jun 30

    Promoters held 5,37,62,672 shares as on March 31, 2026 with zero encumbrance during FY26, indicating no pledging pressure on promoter holdings.

TL;DR: Yatharth Hospital is in expansion mode with a Rs 100 Cr asset acquisition in Gurugram signaling capacity growth in the NCR market. Promoter holdings remain unencumbered, reflecting financial discipline. No visible headwinds from recent news flow. The trend appears constructive with the company investing in growth while maintaining a clean balance sheet posture.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
155
171
167
178
212
218
219
232
258
279
320
342
393
Expenses
113
126
120
131
158
163
164
175
193
215
246
262
301
Operating Profit
41
46
46
47
54
55
55
57
64
65
74
80
92
OPM %
27%
27%
28%
26%
25%
25%
25%
25%
25%
23%
23%
23%
23%
Other Income
1
4
5
6
4
3
4
5
9
9
8
7
4
Interest
6
3
0
0
3
2
2
1
0
0
1
5
7
Depreciation
7
7
8
8
11
16
17
13
15
19
24
30
28
PBT
29
40
44
44
43
40
40
49
59
55
57
52
61
Tax %
35%
30%
33%
13%
29%
23%
24%
20%
28%
25%
25%
14%
26%
Net Profit
19
28
29
38
30
31
30
39
42
41
43
45
45
EPS in Rs
2.91
3.21
3.44
4.47
3.54
3.61
3.16
4.02
4.36
4.28
4.71
4.93
4.88
Figures in ₹ Crores

Profit & Loss

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
71
78
91
136
215
375
478
635
860
1,207
1,334
Expenses
53
60
71
98
147
263
343
453
635
915
1,024
Operating Profit
18
18
20
38
68
112
135
182
225
292
310
OPM %
25%
24%
22%
28%
32%
30%
28%
29%
26%
24%
23%
Other Income
0
0
0
0
1
2
3
16
16
26
29
Interest
6
5
7
20
20
23
23
11
12
7
13
Depreciation
7
6
8
21
21
28
28
29
57
88
101
PBT
5
8
5
-2
28
63
88
157
172
224
225
Tax %
41%
23%
21%
-18%
30%
30%
25%
27%
24%
24%
—
Net Profit
3
6
4
-2
20
44
66
114
131
170
174
EPS in Rs
2.21
3.75
2.43
-0.79
11.09
6.74
10.04
13.33
13.55
18.2
18.8
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
14
16
16
16
16
66
66
86
96
96
Reserves
29
41
39
38
56
51
117
788
1,509
1,684
Borrowings
85
125
175
194
193
264
267
85
12
264
Other Liabilities
10
11
26
39
43
45
36
60
114
237
Total Liabilities
138
193
257
287
309
426
486
1,019
1,731
2,282
Fixed Assets
54
53
164
189
251
303
299
442
605
1,250
CWIP
64
110
65
62
0
0
0
0
222
102
Investments
0
0
0
0
0
0
0
0
74
2
Other Assets
20
30
27
36
58
123
187
577
829
928
Total Assets
138
193
257
287
309
426
486
1,019
1,731
2,282
Figures in ₹ Crores

Cash Flow

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
25
17
17
39
44
60
64
-3
150
205
Investing
-50
-51
-78
-43
-21
-52
-20
-226
-420
-598
Financing
26
43
47
5
-19
-1
-18
304
520
254
Net Cash Flow
1
9
-13
1
3
7
26
75
249
-140
Free Cash Flow
24
16
-60
-4
24
21
44
-96
-161
-112
CFO/OP
148
103
99
109
67
65
75
22
78
98
Figures in ₹ Crores

Ratios

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
58
44
48
45
62
83
82
131
128
113
Inventory Days
47
42
88
72
—
—
—
—
—
32
Days Payable
127
106
490
347
—
—
—
—
—
171
Cash Conversion Cycle
-22
-20
-354
-229
62
83
82
131
128
-26
Working Capital Days
44
29
-75
-89
-18
0
29
118
109
80
ROCE %
—
8%
6%
7%
18%
26%
27%
24%
14%
12%

Shareholding Pattern

As of Jun 2026
Promoters 55.80%
Public 19.83%
DIIs 10.84%
Others 7.91%
FIIs 5.62%
Total 100.00%
  Mar 2022Jun 2023Aug 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
96.91%
66.33%
66.33%
66.33%
66.44%
66.54%
66.54%
66.54%
61.44%
61.64%
61.64%
61.64%
55.80%
55.80%
55.80%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
3.99%
4.89%
6.28%
9.78%
4.45%
4.34%
6.50%
6.18%
5.25%
5.62%
DIIs
0.00%
9.07%
6.74%
8.88%
8.81%
9.33%
9.41%
6.98%
11.50%
13.56%
13.52%
8.70%
11.01%
12.00%
10.84%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
0.00%
16.00%
16.00%
10.12%
12.82%
11.98%
12.11%
14.19%
11.83%
14.87%
15.29%
17.28%
20.31%
20.47%
19.83%
Others
3.09%
8.59%
10.93%
14.67%
11.92%
8.15%
7.04%
6.01%
5.45%
5.48%
5.21%
5.88%
6.70%
6.48%
7.91%
No. of Shareholders
7
1,65,190
1,65,190
50,113
51,743
46,567
51,916
62,616
73,251
85,668
81,440
91,434
96,221
99,117
96,264

Documents

Frequently Asked Questions about Yatharth Hospital & Trauma Care Services Ltd

What does Yatharth Hospital & Trauma Care Services Ltd do?
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]
Where is Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) listed?
Yatharth Hospital & Trauma Care Services Ltd is listed on the Indian stock exchanges. It is listed on NSE: YATHARTH and BSE: 543950. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Yatharth Hospital & Trauma Care Services Ltd belong to?
Yatharth Hospital & Trauma Care Services Ltd operates in the Healthcare sector within the Healthcare Services industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Yatharth Hospital & Trauma Care Services Ltd?
Yatharth Hospital & Trauma Care Services Ltd has a market capitalisation of approximately ₹8261.42 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Yatharth Hospital & Trauma Care Services Ltd?
The Price-to-Earnings (PE) ratio of Yatharth Hospital & Trauma Care Services Ltd is 45.43. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Yatharth Hospital & Trauma Care Services Ltd?
Over the past 52 weeks, Yatharth Hospital & Trauma Care Services Ltd has traded between a low of ₹538.25 and a high of ₹919.5. This range helps investors understand the stock's price volatility and recent trading levels.
Does Yatharth Hospital & Trauma Care Services Ltd pay dividends?
Yes, Yatharth Hospital & Trauma Care Services Ltd has a dividend yield of 0.06%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Yatharth Hospital & Trauma Care Services Ltd?
Yatharth Hospital & Trauma Care Services Ltd has a Return on Equity (ROE) of 7.97%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Yatharth Hospital & Trauma Care Services Ltd on Tapetide?
On Tapetide, you can view Yatharth Hospital & Trauma Care Services Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]

Website yatharthhospitals.com
Listed 2023-08-07
Face Value ₹ 10
Issued Size 9,63,54,357

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List